A 67-Year-Old With $750,000 in Pfizer, Enterprise Products and UPS Collects $3,765 a Month in Dividends. How Safe Is Each Check?

Bobby Sankhagowit • 6 minute read
Reviewed by: Bobby Sankhagowit
Last updated Nov 17, 2026

@Ali Raza via Canva, @Laura Villela Beauty Designer | Brasil from Pexels via Canva

Key Takeaways

  • At today’s prices, a hypothetical $750,000 portfolio split evenly across Pfizer, Enterprise Products Partners and UPS pays about $45,200 a year in dividends, or about $3,760 a month.
  • Enterprise Products Partners’ distribution looks the safest of the three, covered 1.69x by distributable cash flow in fiscal 2025.
  • UPS’s free cash flow is recovering, and dividends took 85% of it over the twelve months to Sept. 30, 2026.
  • Pfizer’s dividend has the least coverage, at 89% of free cash flow, and halving it would cut the portfolio’s income to about $37,600 a year.

A 6% yield is hard to resist when you’re 67 and living off your portfolio.

Let’s take a hypothetical 67-year-old retiree with $750,000 split evenly across Pfizer (PFE), Enterprise Products Partners (EPD) and United Parcel Service (UPS).

Together, they pay about $45,200 a year in dividends, or about $3,760 a month. That’s a 6.0% yield on this part of the portfolio. (Of course, no one should ever own just three stocks.)

Each stock supplies about a third of that dividend check, but the cash behind each one looks very different:

StockSharesCostIncome a yearShare of incomeCoverage
Pfizer (PFE)8,812$249,996$15,15733%89% of free cash flow (TTM)
Enterprise Products Partners (EPD)6,751 units$249,990$15,12234%1.69x distributable cash flow (fiscal 2025)
United Parcel Service (UPS)2,271$249,969$14,89833%85% of free cash flow (TTM)

Source: TIKR, at today’s prices, with dividends at each company’s current annual rate. Pfizer’s coverage is for the twelve months to June 28, 2026, and UPS’s is for the twelve months to Sept. 30, 2026.

6 safe dividend stocks paying retirees 6%+ yields

There are over 100 stocks paying 6%+ annual dividends today.

But after an extensive investment review leveraging TIKR’s proprietary data, we now believe only six of them are truly safe for retirees.

They’re all yours as part of our new investment report. Learn more about how to get access right here.

Pfizer’s check rests on its newer drugs

Pfizer’s third-quarter revenue was $16.6 billion, relatively flat operationally from a year earlier. Launched and acquired products such as Padcev and Nurtec grew 32%, while Paxlovid fell 63%. On Nov. 3, management raised its 2026 guidance for revenue to $62.0-$64.0 billion and for adjusted EPS to $2.95-$3.05.

The harder stretch comes next. Ibrance, Xtandi and Eliquis outside the US are losing exclusivity. Cecile Guegan, named CFO on Nov. 3, said 2027 guidance will reflect two Pfizer products getting Medicare’s negotiated prices that year.

That’s a lot to absorb when the dividend already eats up 89% of free cash flow over the twelve months to June 28, 2026. Free cash flow fell short of the dividend in fiscal 2023 and again in fiscal 2025:

Bar chart from TIKR of Pfizer's free cash flow vs. common dividends paid, $ billions, fiscal 2016–2025.
Pfizer (PFE): free cash flow vs. common dividends paid, $ billions, fiscal 2016–2025 (TIKR)

Management isn’t worried. On Pfizer’s August call, Chairman and CEO Albert Bourla said, “We feel extremely confident that we will — even the most stretched scenarios that we are running, we will be able to maintain our dividend.”

Note the word: maintain. Pfizer’s Oct. 6 declaration kept the quarterly dividend at $0.43 a share, its 352nd consecutive quarterly dividend.

Enterprise has cash to spare

Enterprise is riding the Permian. In the third quarter, its Permian natural gas processing volumes hit a record 4.6 Bcf/d, up 12% from a year earlier, and adjusted EBITDA climbed 16% to $2.8 billion. On Oct. 8, it raised its quarterly distribution 2.8% from a year earlier, to $0.56 a unit. (Enterprise is an MLP, so this retiree owns units, collects distributions and gets a K-1 at tax time.)

Distributable cash flow covered the distribution 1.69x in fiscal 2025. Coverage hasn’t dropped below 1.58x in any year since fiscal 2018:

Bar chart from TIKR of Enterprise Products Partners' distributions per unit vs. distributable cash flow per unit, $ per unit, fiscal 2016–2025.
Enterprise Products Partners (EPD): distributions per unit vs. distributable cash flow per unit, $ per unit, fiscal 2016–2025 (TIKR)

Analysts expect 1.86x for fiscal 2026, on $4.17 a unit of distributable cash flow. The main risk is slower growth. Co-CEO Jim Teague expects EBITDA growth in 2027 to be more modest than this year’s.

UPS is getting smaller on purpose

UPS is chasing better-paying packages and letting others go. In the third quarter, its US average daily volume fell 3.3% as it deliberately cut Amazon volume. Revenue still rose 6.7% to $22.9 billion. Its operating margin slipped to 7.6% from 8.4%, though.

The dividend has sat at $1.64 a share a quarter since early 2025, and the Nov. 4 declaration kept it there. Free cash flow fell short of the dividend in fiscal 2023 and again in fiscal 2025:

Bar chart from TIKR of United Parcel Service's free cash flow vs. common dividends paid, $ billions, fiscal 2016–2025.
United Parcel Service (UPS): free cash flow vs. common dividends paid, $ billions, fiscal 2016–2025 (TIKR)

Coverage is coming back. Dividends took 85% of free cash flow over the twelve months to Sept. 30, 2026. For all of fiscal 2026, analysts expect 88%, a big improvement on fiscal 2025’s 113%.

That matches management’s Oct. 27 guidance: about $6.1 billion of adjusted free cash flow and around $5.4 billion of dividends this year. CFO Brian Dykes expects free cash flow “to continue to move up and improve our dividend coverage as we grow back into the dividend payout ratio that we’ve talked about for a long time.”

Enterprise’s check is the one I’d count on most

All three yield about 6%, so this retiree isn’t getting paid anything extra for thinner coverage. Enterprise’s distribution looks the safest of the three to me, with room to spare and raises still coming. UPS’s dividend is getting safer as its free cash flow recovers, though I wouldn’t expect raises until coverage settles.

Pfizer’s dividend has the least coverage, so it’s the one I’d stress-test. That doesn’t make it risky. Guidance just went up, and Pfizer expects to deliver nearly all of its $7.2 billion of net cost savings by the end of 2026. Still, if Pfizer halved its dividend, this retiree’s income would fall to about $37,600 a year. If it stopped paying altogether, the income would fall to about $30,000.

Bottom line: Pfizer’s check looks safe to me for now, and I’d plan around it staying flat. Its 2027 guidance is the next thing I’d watch.

Enjoy your retirement in style with these safe 6%+ dividend yields

Dividends can hold the key to enormous wealth. But only if you buy the right ones.

Picking the right high-yield dividend stock can be the difference between a dream retirement…and scraping by every month, waiting for the next Social Security check to clear.

We’ve identified six stocks yielding 6%+ that we believe every retiree should know about right now.

Learn more here.

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required